Key facts
- It has raised $2.2M; the latest was Seed Round ($2.2M) in Jan 2026.
- Notable investors include Phoenix Court, Cory Levy, Creator Fund, Konstantin Von Unger.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Anzen Industries
- ·The full record, as it builds
Funding rounds
No funding rounds for Anzen Industries are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anzen Industries
Developer of reusable, low-infrastructure enzyme reactors designed to manufacture complex molecules efficiently. The company's platform combines proprietary enzyme reactor technology, enzyme immobilisation techniques, and AI-driven design to allow biochemical reactions outside living cells, operates within small, modular reactors, supporting flexible and cost-effective scaling while reducing reliance on capital-intensive infrastructure, enabling users to get enzyme reactor technology and simplify their process.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 2
- Website
- anzenindustries.com/
- Ownership
- Privately Held (backing)
Anzen Industries doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anzen Industries shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anzen Industries in its N-PORT filings yet. We sweep new filings monthly.